###begin article-title 0
###xml 35 36 35 36 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 51 53 51 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12</sub>
###xml 157 162 <span type="species:ncbi:9606">women</span>
Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Brazilian women
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 144 193 144 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5,10-methylenetetrahydrofolate reductase (MTHFR) </italic>
###xml 197 217 197 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">methionine synthase </italic>
###xml 218 221 218 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR</italic>
###xml 347 352 <span type="species:ncbi:9606">women</span>
Several studies have determined that dietary intake of B vitamins may be associated with breast cancer risk as a result of interactions between 5,10-methylenetetrahydrofolate reductase (MTHFR) and methionine synthase (MTR) in the one-carbon metabolism pathway. However, the association between B vitamin intake and breast cancer risk in Brazilian women in particular has not yet been investigated.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 148 149 148 149 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 164 167 164 167 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12 </sub>
###xml 262 268 262 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 290 294 290 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 97 102 <span type="species:ncbi:9606">women</span>
A case-control study was conducted in Sao Paulo, Brazil, with 458 age-matched pairs of Brazilian women. Energy-adjusted intakes of folate, vitamin B6, and vitamin B12 were derived from a validated Food Frequency Questionnaire (FFQ). Genotyping was completed for MTHFR A1298C and C677T, and MTR A2756G polymorphisms. A logistical regression model was used to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs).
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 43 44 43 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 58 61 58 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12 </sub>
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 352 353 352 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 353 359 353 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trend </italic>
###xml 353 359 353 359 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>trend </italic></sub>
###xml 373 377 373 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 501 502 501 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 502 508 502 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trend </italic>
###xml 502 508 502 508 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>trend </italic></sub>
###xml 607 613 607 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 668 670 668 670 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6 </sub>
###xml 699 705 699 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 759 762 759 762 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12 </sub>
###xml 315 320 <span type="species:ncbi:9606">women</span>
Neither dietary intake of folate, vitamin B6, or vitamin B12 nor MTHFR polymorphisms were independently associated with breast cancer risk. Analysis stratified by menopausal status showed a significant association between placement in the highest tertile of folate intake and risk of breast cancer in premenopausal women (OR = 2.17, 95% CI: 1.23-3.83; Ptrend = 0.010). The MTR 2756GG genotype was associated with a higher risk of breast cancer than the 2756AA genotype (OR = 1.99, 95% CI = 1.01-3.92; Ptrend = 0.801), and statistically significant interactions with regard to risk were observed between the MTHFR A1298C polymorphism and folate (P = 0.024) or vitamin B6 (P = 0.043), and between the MTHFR C677T polymorphism and folate (P = 0.043) or vitamin B12 (P = 0.022).
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 59 60 59 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 75 78 75 78 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12 </sub>
###xml 191 195 191 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 323 329 323 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 176 181 <span type="species:ncbi:9606">women</span>
###xml 232 237 <span type="species:ncbi:9606">women</span>
MTHFR polymorphisms and dietary intake of folate, vitamin B6, and vitamin B12 had no overall association with breast cancer risk. However, increased risk was observed in total women with the MTR 2756GG genotype and in premenopausal women with high folate intake. These findings, as well as significant interactions between MTHFR polymorphisms and B vitamins, warrant further investigation.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 283 284 283 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 285 286 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 347 396 347 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5,10-methylenetetrahydrofolate reductase (MTHFR) </italic>
###xml 630 631 630 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 632 633 632 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 652 658 652 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 718 724 718 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 756 757 756 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 758 759 758 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 762 787 762 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Methionine synthase (MTR)</italic>
###xml 890 894 890 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 902 903 902 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 904 905 904 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
Folate and other methyl-related B vitamins are essential nutrients which play important roles in DNA synthesis (genetics), repair, and methylation (epigenetics). These roles in turn indicate a potential association for these vitamins with the development of several types of cancer [1-3]. For example, in one folate metabolism pathway, the enzyme 5,10-methylenetetrahydrofolate reductase (MTHFR) irreversibly catalyzes the conversion of 5,10-methylenetetrahydrofolate (5,10-methylene THF) to 5-methyltetrahydrofolate (5-methyl THF), the methyl donor in DNA methylation. In another, folate leads to purine synthesis in DNA repair [2-4]. Activity of the MTHFR gene is attenuated by two common genetic polymorphisms, the MTHFR C677T and A1298C polymorphisms [2,5]. Methionine synthase (MTR), which catalyzes the remethylation of homocysteine to methionine, has the common genetic polymorphism MTR A2756G [5,6].
###end p 11
###begin p 12
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 126 127 126 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 128 129 128 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 160 161 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 318 319 318 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 359 365 359 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 369 373 369 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 388 389 388 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 390 391 390 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 435 441 435 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 481 482 481 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 483 485 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 507 508 507 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 509 511 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 551 557 551 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 602 604 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 619 623 619 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 653 654 653 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 728 734 728 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 781 782 781 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 783 785 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 976 978 976 978 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6 </sub>
###xml 1008 1014 1008 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 1027 1030 1027 1030 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12 </sub>
###xml 1047 1051 1047 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 1052 1053 1052 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1054 1055 1054 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1056 1058 1056 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1059 1061 1059 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1184 1185 1184 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1186 1187 1186 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1325 1326 1325 1326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1327 1329 1327 1329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 106 111 <span type="species:ncbi:9606">women</span>
###xml 151 156 <span type="species:ncbi:9606">women</span>
Several studies have suggested an inverse association between folate intake and breast cancer risk in all women [7-13], pre- [7,8], and postmenopausal women [7-9,12,14,15]. However, recent meta-analysis has shown no clear overall association between folate intake or folate levels in the blood and breast cancer risk [2,16]. A number of studies have examined MTHFR and MTR polymorphisms [4-6,17-25] and found that variant genotypes of MTHFR C677T are associated with an increased [4,17,22-25] or decreased [5,20] risk of breast cancer, while those of MTHFR A1298C are associated with a decreased risk [24] and those of MTR A2756G with a decreased risk [6]. Several studies have further reported on the interaction between these MTHFR genotypes and folate intake in affecting risk [4,19]. In addition to the influence of genotype, DNA methylation and synthesis are also subject to the effects of other vitamins relevant to the one-carbon metabolism pathway, including vitamin B6 (pyridoxine) as a cofactor of MTHFR and vitamin B12 as a cofactor of MTR [4,6,19,26]. Although a role for genotype in modifying the association between dietary intake and disease is biologically plausible [2,4], research into the protective effects of increasing dietary intake of these B vitamins against breast cancer risk remains inconclusive [2,27].
###end p 12
###begin p 13
###xml 146 152 146 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 156 160 156 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 541 547 541 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 551 555 551 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 276 281 <span type="species:ncbi:9606">women</span>
###xml 672 677 <span type="species:ncbi:9606">women</span>
In our similar previous case-control study conducted in a Japanese population, we found no significant association between dietary folate intake, MTHFR and MTR genotype, and breast cancer risk [28]. Although the incidence of breast cancer is higher in Brazilian than Japanese women [29], the association between B vitamin intake in the diet, relevant genotypes, and breast cancer risk in Brazilian populations has not been investigated. Here, we conducted a hospital-based case-control study in Sao Paulo, Brazil, to investigate the role of MTHFR and MTR polymorphisms in modifying the association of folate and other B vitamin intake with breast cancer risk in Brazilian women.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Subjects
###end title 15
###begin p 16
###xml 51 59 <span type="species:ncbi:9606">patients</span>
###xml 299 307 <span type="species:ncbi:9606">patients</span>
###xml 564 572 <span type="species:ncbi:9606">patients</span>
###xml 812 820 <span type="species:ncbi:9606">patients</span>
###xml 954 962 <span type="species:ncbi:9606">patients</span>
Eligible cases were a consecutive series of female patients aged 20-74 years with newly diagnosed and histologically confirmed invasive breast cancer. Cases were recruited between 2001 and 2006 at eight hospitals in Sao Paulo which historically treat a relatively large number of Japanese-Brazilian patients. Eligible controls confirmed not to have any cancer were selected from the same hospitals, with one control matched to each case by age (within 5 years) and ethnicity (Caucasian, African, Asian, or mixed) during the study period. Primary reasons for study patients visiting a hospital included health check-up (52%), treatment for gynecological (13%; 64% of which were uterine myoma), urological (8%), and dermatological conditions (6%), clinical examination (8%), and others. Of the eligible cases, 472 patients (389 non-Japanese Brazilian [99%] and 83 Japanese-Brazilian [91%]) gave written informed consent, while among potential controls, 22 patients refused, resulting in a total of 472 matched pairs ultimately enrolled. The study was approved by the Comissao Nacional de Etica em Pesquisa (CONEP), Brasilia, Brazil, and by the Institute Review Board of the National Cancer Center, Tokyo, Japan, in 2000.
###end p 16
###begin title 17
Data Collection and Dietary Assessment
###end title 17
###begin p 18
###xml 3 9 <span type="species:ncbi:9606">person</span>
In-person interviews were conducted by trained interviewers using a structured questionnaire which included questions on demographic characteristics, medical history, family history of cancer, anthropometric factors, smoking habits, physical activities, menstrual and reproductive factors, as well as a self-quantitative FFQ with 118 food terms.
###end p 18
###begin p 19
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 744 746 744 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 870 871 870 871 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 886 889 886 889 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12 </sub>
###xml 890 892 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 90 102 <span type="species:ncbi:9606">participants</span>
###xml 129 141 <span type="species:ncbi:9606">participants</span>
###xml 311 319 <span type="species:ncbi:9606">patients</span>
###xml 378 386 <span type="species:ncbi:9606">patients</span>
The FFQ used here, developed specifically for this study to estimate dietary intake among participants, inquired about how often participants consumed individual food items (frequency of consumption), as well as about representative relative sizes compared with standard portions in the preceding year (control patients) or one year before their breast cancer diagnosis (cancer patients). Daily food intake was calculated by multiplying frequency by standard portion size and relative size for each food item in the FFQ. Daily intake of nutrients was calculated using the United States Department of Agriculture (USDA) food composition tables [30] and the Fifth Revised and Enlarged Edition of the Standard Tables of Food Composition in Japan [31] for intake regarding Japanese-specific foods. The regression-residual model was used to adjust intake of folate, vitamin B6, and vitamin B12 [32]. Our FFQ included questions on supplement use, but nutrient intake data from supplements were not included in analyses, as no comprehensive data for supplements were available.
###end p 19
###begin p 20
###xml 322 323 322 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 347 349 347 349 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12</sub>
###xml 117 122 <span type="species:ncbi:9606">women</span>
The validity of nutrient intake estimated from the FFQ was evaluated in a subsample of the control group. Fifty-five women completed a 4-day dietary record (DR) in two seasons. Spearman's correlation coefficient between energy-adjusted nutrient intakes estimated from the FFQ and DR was 0.30 for folate, 0.38 for vitamin B6, and 0.33 for vitamin B12.
###end p 20
###begin title 21
Genotype of Polymorphisms
###end title 21
###begin p 22
###xml 171 175 165 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 302 308 294 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 312 316 304 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 412 416 404 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 696 718 686 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N-acetyltransferase 2 </italic>
###xml 719 723 709 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT2</italic>
###xml 726 750 716 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cytochrome P450c17&#945; </italic>
###xml 751 756 737 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP17</italic>
###xml 759 769 745 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aromatase </italic>
###xml 770 775 756 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP19</italic>
###xml 782 802 768 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cytochrome P450 2E1 </italic>
###xml 803 809 789 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP2E1</italic>
Peripheral blood samples were obtained from each subject and stored at -80degreesC until analysis. Genomic DNA samples were extracted from the blood using QIAGEN FlexiGene(R) DNA kits in accordance with the manufacturer's protocol. Genotyping of the three single-nucleotide polymorphisms (SNPs) in the MTHFR and MTR genes was performed by a commercial laboratory (Genetic Lab., Inc., Sapporo, Japan) using TaqMan(R) SNP Genotyping Assays developed by Applied Biosystems (Framingham, MA, USA). Cases and matched controls were analyzed in the same well by laboratory personnel blinded to case-control status. To assess quality control, we conducted laboratory genotyping of six SNPs of four genes (N-acetyltransferase 2 [NAT2], cytochrome P450c17alpha [CYP17], aromatase [CYP19], and cytochrome P450 2E1 [CYP2E1]) using approximately 25% of samples from the present study, although SNPs used in the present study were not included. The concordance rates between Genetic Lab. and our laboratory varied between 97.5% and 99.2% for the six SNPs.
###end p 22
###begin title 23
Data Analysis
###end title 23
###begin p 24
###xml 168 173 <span type="species:ncbi:9606">women</span>
Study subjects with markedly low or high total energy intake (<500 or >/=4000 kcal) or without DNA samples were excluded from the study, leaving 458 pairs of Brazilian women for analysis (379 non-Japanese Brazilian and 79 Japanese-Brazilian pairs). ORs and 95% CIs for associations between dietary intake, polymorphisms, and risk of breast cancer were calculated by the conditional logistical model, and statistical significance was examined by the Wald chi-square test. Baseline characteristics between cases and controls were compared by the Cochran-Mantel-Haenszel test using matched-pair strata. Deviation from the Hardy-Weinberg equilibrium in genotype frequencies was assessed with the chi-square test.
###end p 24
###begin p 25
###xml 714 715 714 715 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 730 733 730 733 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12 </sub>
In the primary analysis of all subjects, risk factors identified by univariate analysis as independently related to disease risk, including smoking habit, alcohol consumption, number of live births, and a moderate level of physical activity in the preceding 5 years, were adjusted in multivariable analyses. Other potential confounders such as age at menarche, age at first live birth, breast feeding, number of pregnancies, and breast cancer in first-degree relatives were not independently associated with breast cancer risk, nor did they substantially modify the effects when tested in the multivariable model (less than 10% change in strength), and were thus not retained. Nutrient intakes of folate, vitamin B6, and vitamin B12 were categorized into tertiles for total study subjects based on the distribution among controls, with the lowest tertiles considered as the reference categories.
###end p 25
###begin p 26
###xml 132 138 132 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 160 164 160 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
To increase statistical power, respective genotypes of less-frequent polymorphisms were also combined into two groups. Genotypes of MTHFR 677CC and 1298AA, and MTR 2756AA were considered as the referent group. With regard to evaluation of the interactive effects of SNPs and dietary intakes on breast cancer risk, the combined effects of SNPs and dietary intakes were assessed by adding the multiplicative interaction product (genotype x dietary intake) to the final model as indicator variables.
###end p 26
###begin p 27
###xml 391 393 391 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 39 47 <span type="species:ncbi:9606">patients</span>
In a secondary analysis, we stratified patients by menopause status, alcohol consumption, and vitamin supplement use using an unconditional logistic model which adjusted for identified risk factors as well as age and ethnicity. Further, trend testing was conducted by treating each categorized variable as a continuous term and entering the variable into the logistic regression models. All p values reported were two-sided, and the significance level was set at p < 0.05. All analyses were conducted with SAS 9.02 (SAS Institute Inc., Cary, NC, USA).
###end p 27
###begin title 28
Results
###end title 28
###begin p 29
###xml 76 77 76 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
Characteristics of case and control subjects at baseline are shown in Table 1. The breast cancer case group tended to include more smokers and have higher energy intake, but lower alcohol consumption, less moderate physical activity, fewer live births, and lower vitamin supplement use than the control group.
###end p 29
###begin p 30
###xml 79 84 <span type="species:ncbi:9606">women</span>
Characteristics of breast cancer and control subjects at baseline in Brazilian women
###end p 30
###begin p 31
###xml 0 6 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8224;</sup>
daggerSD, standard deviation.
###end p 31
###begin p 32
###xml 81 83 81 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 115 139 115 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cochran-Mantel-Haenszel </italic>
*Differences between case-control pairs in mean values were tested by the paired t test, and in proportions by the Cochran-Mantel-Haenszel test.
###end p 32
###begin title 33
B Vitamins and Breast Cancer Risk
###end title 33
###begin p 34
###xml 52 53 52 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 68 71 68 71 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12 </sub>
###xml 205 206 205 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 561 563 561 563 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6 </sub>
###xml 192 197 <span type="species:ncbi:9606">women</span>
###xml 270 275 <span type="species:ncbi:9606">women</span>
###xml 430 435 <span type="species:ncbi:9606">women</span>
###xml 520 525 <span type="species:ncbi:9606">women</span>
###xml 698 703 <span type="species:ncbi:9606">women</span>
Using the lowest tertile intake of folate, vitamin B6, and vitamin B12 as reference, no statistically significant association was observed between vitamin intake and breast cancer risk in all women (Table 2). Similar null results were found in Japanese and non-Japanese women, as well as in individuals who refrained from alcohol consumption or vitamin supplement use (data not shown). An increased risk was seen in premenopausal women in the highest tertile of folate intake (P for trend = 0.010) and in postmenopausal women in the highest tertile of vitamin B6 intake (P for trend = 0.047). Similarly, a statistically significant increase in risk was seen for high folate intake in premenopausal women of non-Japanese Brazilian ethnicity (in the highest tertile of folate intake, OR = 1.89, 95% CI = 1.06-3.38; P for trend = 0.037), but not in those of Japanese-Brazilian ethnicity.
###end p 34
###begin p 35
###xml 88 93 <span type="species:ncbi:9606">women</span>
Association between energy-adjusted nutrient intake and breast cancer risk in Brazilian women
###end p 35
###begin p 36
###xml 89 90 89 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 105 108 105 108 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12 </sub>
###xml 128 133 <span type="species:ncbi:9606">women</span>
*Energy-adjusted intakes were categorized among controls by tertiles of folate, vitamin B6, and vitamin B12 for total Brazilian women.
###end p 36
###begin p 37
###xml 0 6 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8224;</sup>
daggerAdjusted for smoking status (never/ever), alcohol consumption (never/ever), moderate physical activity in the preceding 5 years (no/yes), and number of live births (nulliparous/1-2/>/=3).
###end p 37
###begin p 38
###xml 0 13 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8225;</sup>
double daggerAdjusted for age group (20-/30-/40-/50-/60-/>/=70), ethnicity (white/mixed/black/yellow), smoking status (never/ever), alcohol consumption (never/ever), moderate physical activity in the preceding 5 years (no/yes), and number of live births (nulliparous/1-2/>/=3).
###end p 38
###begin title 39
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
Polymorphisms of MTHFR and MTR Genes and Breast Cancer Risk
###end title 39
###begin p 40
###xml 42 48 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 103 104 103 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 233 237 233 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 594 600 594 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 821 823 821 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 218 223 <span type="species:ncbi:9606">women</span>
###xml 458 463 <span type="species:ncbi:9606">women</span>
###xml 541 546 <span type="species:ncbi:9606">women</span>
###xml 780 785 <span type="species:ncbi:9606">women</span>
Associations between polymorphisms of the MTHFR or MTR genes and breast cancer risk are shown in Table 3. No deviation from the Hardy-Weinberg equilibrium was observed in the controls. Compared to the reference group, women with the MTR 2756GG genotype had a significantly increased risk of breast cancer (OR = 1.99, 95% CI = 1.01-3.92; P for trend = 0.801), but no other statistically significant associations were observed for all, pre-, or postmenopausal women. Similar null results were found in both non-Japanese and Japanese-Brazilian women (data not shown), although distribution of the MTHFR C677T polymorphism (CC, CT, and TT genotype) in control subjects differed significantly between the non-Japanese Brazilian (51%, 39%, and 10%, respectively) and Japanese-Brazilian women (35%, 52%, and 13%, respectively) (P = 0.038).
###end p 40
###begin p 41
###xml 84 89 <span type="species:ncbi:9606">women</span>
Association between genotype of related enzymes and breast cancer risk in Brazilian women
###end p 41
###begin p 42
###xml 0 6 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8224;</sup>
daggerAdjusted for smoking status (never/ever), alcohol consumption (never/ever), moderate physical activity in the preceding 5 years (no/yes), and number of live births (nulliparous/1-2/>/=3).
###end p 42
###begin p 43
###xml 0 13 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8225;</sup>
double daggerAdjusted for age group (20-/30-/40-/50-/60-/>/=70), ethnicity (white/mixed/black/yellow), smoking status (never/ever), alcohol consumption (never/ever), moderate physical activity in the preceding 5 years (no/yes), and number of live births (nulliparous/1-2/>/=3).
###end p 43
###begin p 44
###xml 54 60 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 78 84 78 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 95 99 95 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 111 117 111 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 127 131 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
We also examined the effects of combined genotypes of MTHFR A1298C and C677T, MTHFR A1298C and MTR A2756G, and MTHFR C677T and MTR A2756G, none of which was statistically significantly associated with the risk of breast cancer compared to their wild genotypes.
###end p 44
###begin title 45
Gene-environment Interactions in Breast Cancer
###end title 45
###begin p 46
###xml 21 27 21 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 109 110 109 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 135 141 135 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 162 166 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 403 409 403 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 479 483 479 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 624 630 624 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 782 788 782 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 919 925 919 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 388 393 <span type="species:ncbi:9606">women</span>
###xml 576 581 <span type="species:ncbi:9606">women</span>
###xml 734 739 <span type="species:ncbi:9606">women</span>
The joint effects of MTHFR and MTR polymorphisms and dietary intake on breast cancer risk are shown in Table 4, in which the genotypes MTHFR 1298AA and 677CC and MTR 2756AA with the lowest tertiles of dietary intake were used as references, with variant allele combinations. Statistically significant positive associations between folate intake and breast cancer risk were observed among women with the MTHFR 1298AA (P for trend = 0.003), 677CT and TT (P for trend = 0.011), and MTR 2756AA genotypes (P for trend = 0.049). An increased risk of breast cancer was seen in those women with the lowest folate intake who had the MTHFR 1298AC and CC genotype (OR = 1.95, 95% CI = 1.18-3.22). In contrast, a decreased risk was seen in those women with the lowest folate intake who had the MTHFR 677CT and TT genotype (OR = 0.60, 95% CI = 0.37-0.97). Statistically significant interactions were detected for folate intake with MTHFR A1298C (P for interaction = 0.024) and C677T polymorphisms (P for interaction = 0.043).
###end p 46
###begin p 47
###xml 138 143 <span type="species:ncbi:9606">women</span>
Combined effects of genotype of related enzymes and energy-adjusted nutrient intakes in all breast cancer cases and controls in Brazilian women
###end p 47
###begin p 48
###xml 89 90 89 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 105 107 105 107 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12</sub>
*Energy-adjusted intakes were categorized among controls by tertiles of folate, vitamin B6, and vitamin B12, respectively.
###end p 48
###begin p 49
###xml 0 6 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8224;</sup>
daggerAdjusted for smoking status (never/ever), alcohol consumption (never/ever), moderate physical activity in the preceding 5 years (no/yes), and number of live births (nulliparous/1-2/>/=3).
###end p 49
###begin p 50
###xml 87 89 87 89 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6 </sub>
###xml 140 146 140 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 269 272 269 272 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12 </sub>
###xml 323 329 323 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 432 438 432 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 471 473 471 473 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6 </sub>
###xml 524 530 524 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 562 565 562 565 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12 </sub>
###xml 125 130 <span type="species:ncbi:9606">women</span>
A marginally positive association was observed between the highest tertile of vitamin B6 intake and breast cancer risk among women with the MTHFR 1298AA genotype (P for trend = 0.061), whereas an inverse association was observed between the highest tertile of vitamin B12 intake and breast cancer risk among those with the MTHFR 677CC genotype (P for trend = 0.073). A statistically significant interaction was detected between the MTHFR A1298C polymorphism and vitamin B6 intake (P for interaction = 0.043) and between the MTHFR C677T polymorphism and vitamin B12 intake (P for interaction = 0.022).
###end p 50
###begin title 51
Discussion
###end title 51
###begin p 52
###xml 72 75 72 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6, </sub>
###xml 88 91 88 91 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12 </sub>
###xml 192 193 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 223 225 223 225 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6 </sub>
###xml 226 227 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 258 261 258 261 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12 </sub>
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
In this study, we found no overall association between folate, vitamin B6, and vitamin B12 intake and the risk of breast cancer. These findings are consistent with previous studies on folate [4,14,16,20,28,33-40], vitamin B6 [4,12,28,35,39,40], and vitamin B12 [8,15,28,39,40].
###end p 52
###begin p 53
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 619 621 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 756 757 752 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 315 320 <span type="species:ncbi:9606">women</span>
###xml 450 455 <span type="species:ncbi:9606">women</span>
###xml 573 578 <span type="species:ncbi:9606">women</span>
###xml 669 674 <span type="species:ncbi:9606">women</span>
###xml 839 844 <span type="species:ncbi:9606">women</span>
Generally, folate is able to prevent the development of tumors before preneoplastic lesions have been established, but conversely increases tumorigenesis once lesions have been established [39,41,42]. Although increased folate intake may be beneficial in populations deficient in this nutrient, increased intake in women with already-sufficient levels of folate may provide no further benefit, or actually be harmful [34]. Folate intake in Brazilian women in the present study (inter-tertile range, 446.2-602.2 mug/day) was higher than that measured in a study of Japanese women (inter-tertile range, 386-501 mug/day) [28] and in a meta-analysis of Caucasian and Asian women (inter-tertile range, 77-255 to 147-359 mug/day and 132-304 to 206-473 mug/day) [2]. In this study, we observed an increased risk of breast cancer in premenopausal women with high folate intake. Folate levels may have been already sufficient in the lower intake group, and thus an increase in intake may on this basis have contributed to tumorigenesis.
###end p 53
###begin p 54
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 460 462 460 462 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6 </sub>
###xml 585 586 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 716 718 716 718 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6 </sub>
###xml 719 721 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 824 826 824 826 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6 </sub>
###xml 158 163 <span type="species:ncbi:9606">women</span>
###xml 302 307 <span type="species:ncbi:9606">women</span>
###xml 359 364 <span type="species:ncbi:9606">women</span>
###xml 571 583 <span type="species:ncbi:9606">participants</span>
###xml 674 679 <span type="species:ncbi:9606">women</span>
###xml 802 807 <span type="species:ncbi:9606">women</span>
Similarly, a study on plasma folate found that concentration was associated with an increase in breast cancer risk in premenopausal but not in postmenopausal women [39]. This study also indicated that the proliferation rate of breast epithelial cells may be higher in premenopausal than postmenopausal women, leaving less time for DNA repair in premenopausal women [39]. Further, a large population-based case-control study reported that high dietary vitamin B6 intake was associated with an increased risk of breast cancer, but did not indicate the menopausal status of participants [8]. In contrast, another study found a decreased risk of breast cancer in postmenopausal women with high plasma levels of vitamin B6 [39]. Our finding of a significant increase in breast cancer risk in postmenopausal women due to vitamin B6 intake may thus be due to chance.
###end p 54
###begin p 55
###xml 238 240 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 505 507 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 508 510 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 568 570 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 231 236 <span type="species:ncbi:9606">women</span>
###xml 999 1004 <span type="species:ncbi:9606">women</span>
A Canadian study found that a high total folate intake, obtained mainly from nutritional supplements, significantly increased breast cancer risk by 32% (highest >853 mug/day versus lowest quintile </=336 mug/day) in postmenopausal women [33]. The authors hypothesized that high folic acid concentrations may contribute to epigenetic changes in gene-regulatory mechanisms, which may result in gene silencing and enhanced cancer development, or may promote the growth of tumors expressing folate receptors [33,41]. However, the mechanism of this effect remains unclear [41]. In our study, however, overall vitamin supplement users (defined as more than once-weekly use for at least one year) accounted for 11.8% of controls, and the distribution of supplement users was similar in the highest and lowest intake groups (data not shown). Because folate and other B vitamin intake in our population was thus obtained primarily from unfortified diets, the increased risk of breast cancer in premenopausal women with high folate intake was unlikely due to supplement use.
###end p 55
###begin p 56
###xml 80 86 80 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 174 180 174 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 359 360 359 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 361 362 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 514 520 514 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 717 718 717 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 817 823 817 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 918 924 918 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 1068 1074 1068 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 1102 1103 1102 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1400 1401 1400 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 352 357 <span type="species:ncbi:9606">women</span>
###xml 499 504 <span type="species:ncbi:9606">women</span>
###xml 1013 1021 <span type="species:ncbi:9606">patients</span>
A recent meta-analysis indicated no overall significant association between the MTHFR C677T polymorphism and breast cancer risk in Caucasians and East Asians, or between the MTHFR A1298C polymorphism and risk in Caucasians [27]. Our study supports the lack of association found in this meta-analysis as well as in others studies in Caucasian and Asian women [1,5,43]. In contrast to another finding of the meta-analysis [27], however, which found an increased risk of breast cancer in premenopausal women with the MTHFR 677CT and TT genotype compared to those with the CC genotype, we did not observe any increase in risk in these groups. Further, contrary to the findings in a previous study conducted in Americans [1], we did not find an increased risk of breast cancer to be related to the genotype combination of MTHFR A1298C and C677T. This lack of concordance in findings may be due to the low proportion of the MTHFR 677T genotype in our study population or to compensation by the folate-replete status of patients for the effects of the variant alleles of the MTHFR A1298C and C677T genotypes [2]. Nevertheless, few studies have achieved conclusive results regarding whether functional polymorphisms in one-carbon metabolizing genes affect breast cancer risk associated with dietary intake of folate and other related B vitamins, the biological plausibility of this scenario notwithstanding [2].
###end p 56
###begin p 57
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 534 538 534 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 584 585 584 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 791 793 791 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 857 861 857 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 948 952 948 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 1082 1087 1082 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTRR </italic>
###xml 1094 1096 1094 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1097 1099 1097 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1145 1151 1145 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cSHMT </italic>
###xml 1160 1162 1160 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1168 1174 1168 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 1181 1183 1181 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1283 1287 1283 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 1305 1311 1305 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 1390 1394 1390 1394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 1399 1404 1399 1404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTRR </italic>
###xml 1407 1413 1407 1413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cSHMT </italic>
###xml 1425 1430 1425 1430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTRR </italic>
###xml 1434 1440 1434 1440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cSHMT </italic>
###xml 1518 1522 1518 1522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
The MTR gene contributes to alterations in the plasma levels of homocysteine and folate; specifically, subjects with the 2756AG and GG genotypes have lower levels of plasma homocysteine or higher levels of serum folate than those with the 2756AA genotype [44,45]. When methionine levels are adequate, these variant polymorphisms with lower enzyme activity may also result in elevated homocysteine levels and DNA hypomethylation [46]. A Polish study reported the possible association between the hetero- and homozygote variants of the MTR A2756G and a decreased risk of breast cancer [6]. In the present study, however, we observed an increased risk of breast cancer in total subjects who had the MTR 2756GG genotype, a finding similar to that reported in a recent study conducted in Taiwan [46]. This observed increase may be due to the linkage between the MTR A2756G polymorphism and other genetic polymorphisms, or to the interaction between the MTR A2756G polymorphism and other genetic polymorphisms related to folate metabolism, such as that for methionine synthase reductase (MTRR G66A) [25,45], cytosolic serine hydroxymethyltransferase (cSHMT C1420T) [21], or MTHFR C677T [47]. However, we observed no statistically significant associations between the combined genotypes of MTR A2756G and either MTHFR A1298C or C667T and breast cancer risk, nor could we test the joint effects of MTR with MTRR or cSHMT genes since MTRR and cSHMT genes were not available in the present study. Given the low frequency of the MTR 2756GG genotype in our study population, the significant finding of our present study may be the result of chance.
###end p 57
###begin p 58
###xml 70 76 70 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 466 467 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 468 469 468 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 593 599 593 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 748 754 748 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 837 843 837 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 909 910 909 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 932 934 932 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 959 961 959 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 992 998 992 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 1219 1221 1219 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1343 1345 1343 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1346 1348 1346 1348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1378 1380 1378 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1381 1383 1381 1383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1535 1541 1535 1541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 1552 1556 1552 1556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 1754 1760 1754 1760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 1796 1802 1796 1802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 1986 1992 1986 1992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 2141 2144 2141 2144 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12 </sub>
###xml 2218 2221 2218 2221 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12 </sub>
###xml 2225 2231 2225 2231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 2291 2294 2291 2294 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12 </sub>
###xml 2331 2333 2331 2333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 2334 2336 2334 2336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 545 550 <span type="species:ncbi:9606">women</span>
###xml 700 705 <span type="species:ncbi:9606">women</span>
###xml 949 957 <span type="species:ncbi:9606">patients</span>
###xml 1517 1525 <span type="species:ncbi:9606">patients</span>
Previous authors have speculated that interactions between folate and MTHFR polymorphism may be elicited to show that (a) the lower activity of variant genotypes may increase the risk of breast cancer at low levels of dietary folate since less 5-methyl THF is made available for DNA methylation, and (b) variant genotypes might provide advantages over the wild genotype in folate-replete conditions since 5,10-methyl THF would be available for nucleotide synthesis [2,4]. Supporting notion (a), we found an increased risk of breast cancer among women with the lowest folate intake who had the MTHFR 1298AC and CC genotype. Contrary to (a), however, we also saw a decrease in breast cancer risk among women with the lowest folate intake who had the MTHFR 677CT and TT genotype. Similar findings of decreased breast cancer risk in variant MTHFR C677T genotypes have been reported in previous studies in German [5], Japanese-American [20], and Chinese patients [10]. The reduced activity of the MTHFR C677T polymorphism was speculated to increase the pool of intracellular 5,10-methylene THF, which protects against potential defects in DNA synthesis, although circulating folate levels (5-methyl THF) tended to be lower [10]. Nevertheless, the inconsistencies in results between this and previous studies may be due to differences in ethnicity [10,19], background dietary status [19,37], or possibly chance. Given the above discussion regarding folate intake level, the increased risk of breast cancer observed here in patients with the MTHFR 1298AA and MTR 2756AA genotype in a higher tertile of folate intake may be due to the harmful effects brought about by excessive intake of folate. Notion (b) suggests that the lower activity of variant alleles of MTHFR A1298C provides advantages over the MTHFR 1298AA genotype, but with the compensation of sufficient folate intake, the lower enzyme activity was attenuated to result in the lack of significant association seen with the variant MTHFR A1298C genotypes in the higher category of folate intake. In addition, the observed trend to a decline in breast cancer risk with increased vitamin B12 intake (P for trend = 0.073) and significant interaction between vitamin B12 and MTHFR C677T polymorphism might be due to the function of vitamin B12 as a cofactor in folate metabolisms [12,19].
###end p 58
###begin p 59
###xml 93 94 93 94 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 109 112 109 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12 </sub>
###xml 1290 1292 1290 1292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 555 563 <span type="species:ncbi:9606">patients</span>
Several limitations of this study warrant mention. First, dietary intake of folate, vitamin B6, and vitamin B12 was assessed after breast cancer diagnosis and was therefore sensitive to recall bias. Case subjects may have been more motivated to recall diet than controls, and their recall may also have been inaccurate, depending on the belief of an association between diet and their disease. Second, although substantially high participation rates among both eligible case and control subjects minimized potential selection bias, the use of cancer-free patients as controls, whose dietary habits may have differed from the general population due to health consciousness or disease concerns, might have lead to selection bias. Third, as our subjects were recruited from eight hospitals in Sao Paulo, Brazil, they may not necessarily be representative of the general Brazilian population, and thus any extrapolation of results to the general population should be done cautiously. Fourth, our validation study found relatively low correlation coefficients between FFQ and DR-based nutrient intake estimates. Further, the validation study indicated that measurement errors in assessing nutrient intake by FFQ were unavoidable, although such random errors tend to result in null associations [48]. Fifth, although our quality control assessment of the genotyping showed high concordance rates between Genetic Lab. and our laboratory, we did not genotype the duplicate blinded samples of SNPs used in the present study and therefore cannot rule out the possibility of misclassification in genotyping status, although its effect on the results might be minimal. Sixth, stratified analyses were performed based on a relatively small number of cases, possibly limiting the interpretability of our results.
###end p 59
###begin title 60
Conclusion
###end title 60
###begin p 61
###xml 145 146 145 146 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 161 163 161 163 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12</sub>
###xml 165 171 165 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTHFR </italic>
###xml 289 293 289 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTR </italic>
###xml 50 55 <span type="species:ncbi:9606">women</span>
###xml 274 279 <span type="species:ncbi:9606">women</span>
###xml 379 384 <span type="species:ncbi:9606">women</span>
In this case-control study conducted in Brazilian women, we found no overall significant associations between dietary intake of folate, vitamin B6, and vitamin B12, MTHFR genotype, and breast cancer risk. However, we did identify an increased risk of breast cancer in total women with the MTR 2756GG genotype, increased risk associated with higher folate intake in premenopausal women, and gene-nutrient interactions. Further studies into these factors will help to elucidate the etiology of breast cancer.
###end p 61
###begin title 62
Abbreviations
###end title 62
###begin p 63
CI: confidence interval; FFQ: food frequency questionnaire; MTHFR: 5,10-methylenetetrahydrofolate reductase; MTR: methionine synthase; OR: odds ratio; SNPs: single-nucleotide polymorphisms.
###end p 63
###begin title 64
Competing interests
###end title 64
###begin p 65
The authors declare that they have no competing interests.
###end p 65
###begin title 66
Authors' contributions
###end title 66
###begin p 67
EM performed the data analysis and drafted the manuscript. MI participated in the study design, coordinated the study and helped with data integrity, analysis, interpretation, and preparation of the manuscript. JI participated in data analysis and interpretation of data. GH involved the study design, supervised the study, contributed to data acquisition and interpretation. IN involved the study design, and contributed to data acquisition and interpretation. SC contributed to data acquisition and interpretation. JM contributed to data acquisition and interpretation. FL contributed to data acquisition and interpretation. ST designed, supervised and coordinated the study and helped with data interpretation and preparation of the manuscript. All authors have read and approved the final manuscript.
###end p 67
###begin title 68
Pre-publication history
###end title 68
###begin p 69
The pre-publication history for this paper can be accessed here:
###end p 69
###begin p 70

###end p 70
###begin title 71
Acknowledgements
###end title 71
###begin p 72
This study was supported by a Grant-in-Aid for Research on Risk of Chemical Substances from the Ministry of Health, Labour and Welfare of Japan, and Grants-in-Aid for Scientific Research on Priority Areas (17015049) and for Young Scientists (B) (17790378 and 19790415) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and Japan Society for the Promotion of Science.
###end p 72
###begin article-title 73
Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence
###end article-title 73
###begin article-title 74
Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk
###end article-title 74
###begin article-title 75
Folate and carcinogenesis: an integrated scheme
###end article-title 75
###begin article-title 76
One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer
###end article-title 76
###begin article-title 77
One-carbon metabolism and breast cancer risk: no association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany
###end article-title 77
###begin article-title 78
Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses
###end article-title 78
###begin article-title 79
Re: dietary folate consumption and breast cancer risk
###end article-title 79
###begin article-title 80
Dietary folate intake and breast cancer risk: results from the Shanghai Breast Cancer Study
###end article-title 80
###begin article-title 81
Dietary intake of selected micronutrients and breast-cancer risk
###end article-title 81
###begin article-title 82
Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan
###end article-title 82
###begin article-title 83
Raw and cooked vegetables, fruits, selected micronutrients, and breast cancer risk: a case-control study in Germany
###end article-title 83
###begin article-title 84
###xml 91 96 <span type="species:ncbi:9606">women</span>
Folate, vitamin B(6), and vitamin B(12) intake and the risk of breast cancer among Mexican women
###end article-title 84
###begin article-title 85
Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer
###end article-title 85
###begin article-title 86
A prospective study of folate intake and the risk of breast cancer
###end article-title 86
###begin article-title 87
###xml 86 91 <span type="species:ncbi:9606">women</span>
Folate, vitamin B12 and postmenopausal breast cancer in a prospective study of French women
###end article-title 87
###begin article-title 88
Folate and risk of breast cancer: a meta-analysis
###end article-title 88
###begin article-title 89
Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer
###end article-title 89
###begin article-title 90
MTR and MTRR Polymorphisms, Dietary Intake, and Breast Cancer Risk
###end article-title 90
###begin article-title 91
MTHFR polymorphisms, dietary folate intake, and breast cancer risk: results from the Shanghai Breast Cancer Study
###end article-title 91
###begin article-title 92
MTHFR polymorphisms, diet, HRT, and breast cancer risk: the multiethnic cohort study
###end article-title 92
###begin article-title 93
###xml 105 110 <span type="species:ncbi:9606">women</span>
Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan
###end article-title 93
###begin article-title 94
Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis
###end article-title 94
###begin article-title 95
Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis
###end article-title 95
###begin article-title 96
Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks
###end article-title 96
###begin article-title 97
One-carbon metabolism-related gene polymorphisms and risk of breast cancer
###end article-title 97
###begin article-title 98
Biomarkers of nutrient exposure and status in one-carbon (methyl) metabolism
###end article-title 98
###begin article-title 99
Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis
###end article-title 99
###begin article-title 100
Dietary Intake of Folate, Vitamin B2, Vitamin B6, and Vitamin B12, Genetic Polymorphism of Related Enzymes, and Risk of Breast Cancer: a Case-control Study in Japan
###end article-title 100
###begin article-title 101
Cancer incidence rates among Japanese immigrants in the city of Sao Paulo, Brazil, 1969-78
###end article-title 101
###begin article-title 102
USDA National Nutrient Database for Standard Reference, Release 18
###end article-title 102
###begin article-title 103
Total energy intake: implications for epidemiologic analyses
###end article-title 103
###begin article-title 104
Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
###end article-title 104
###begin article-title 105
Folate and cancer prevention: a closer look at a complex picture
###end article-title 105
###begin article-title 106
A prospective study on folate, B12, and pyridoxal 5'-phosphate (B6) and breast cancer
###end article-title 106
###begin article-title 107
###xml 77 82 <span type="species:ncbi:9606">women</span>
Methyl-group dietary intake and risk of breast cancer among African-American women: a case-control study by methylation status of the estrogen receptor alpha genes
###end article-title 107
###begin article-title 108
Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR)
###end article-title 108
###begin article-title 109
Does dietary folate intake modify effect of alcohol consumption on breast cancer risk? Prospective cohort study
###end article-title 109
###begin article-title 110
###xml 71 76 <span type="species:ncbi:9606">women</span>
Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in women
###end article-title 110
###begin article-title 111
###xml 90 95 <span type="species:ncbi:9606">women</span>
Nutrients involved in one-carbon metabolism and risk of breast cancer among premenopausal women
###end article-title 111
###begin article-title 112
Does a high folate intake increase the risk of breast cancer?
###end article-title 112
###begin article-title 113
###xml 85 90 <span type="species:ncbi:9606">women</span>
B-vitamin intake, one-carbon metabolism, and survival in a population-based study of women with breast cancer
###end article-title 113
###begin article-title 114
###xml 84 89 <span type="species:ncbi:9606">women</span>
Methylenetetrahydrofolate reductase polymorphism, diet, and breast cancer in Korean women
###end article-title 114
###begin article-title 115
Polymorphisms of methionine synthase and methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: a case-control analysis
###end article-title 115
###begin article-title 116
###xml 117 122 <span type="species:ncbi:9606">Women</span>
Polymorphisms of Key Enzymes in Homocysteine Metabolism Affect Diet Responsiveness of Plasma Homocysteine in Healthy Women
###end article-title 116
###begin article-title 117
Breast cancer risk associated with multigenotypic polymorphisms in folate-metabolizing genes: a nested case-control study in Taiwan
###end article-title 117
###begin article-title 118
B-vitamin intake, metabolic genes, and colorectal cancer risk (United States)
###end article-title 118
###begin article-title 119
###xml 93 96 <span type="species:ncbi:9606">men</span>
Low intake of vitamin B-6 is associated with increased risk of colorectal cancer in Japanese men
###end article-title 119

